-
Mashup Score: 0A History of #BCSM and Insights for Patient-Centered Online Interaction and Engagement - 12 month(s) ago
Purpose: Participation in cancer support groups can provide a sense of community and may better prepare patients for interactions with their health care team. Online interactions may overcome some barriers to in-person support group participation. #BCSM (breast cancer social media), the first cancer support community established on Twitter, was founded in 2011 by two breast cancer survivors. The…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies - 12 month(s) ago
Purpose: This study sought to describe the changes in immune response to a third dose of either Pfizer’s or Moderna’s COVID-19 mRNA vaccine (3V) among patients with hematologic malignancies, as well as associated characteristics Methods: This retrospective cohort study analyzed pre-3V and post-3V data on 493 patients diagnosed with hematologic malignancies across a large Midwestern health system…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Real World Third COVID19 Vaccine Dosing and Antibody Response in Patients with Hematologic Malignancies [Jul 18, 2022] @mtmdphd , Hallmeyer, @vrepublic , Liao, @mullane_michael @scmedlin , Copeland, @JimW9200 @JPCRR https://t.co/CnXLOfmBVw #COVID19nCancer #COVID19Vaccine #IDonc https://t.co/D61nCmzPXC
-
-
Mashup Score: 0Coordinating an Oncology Precision Medicine Clinic Within an Integrated Health System: Lessons Learned in Year One - 12 month(s) ago
Precision medicine is a term describing strategies to promote health and prevent and treat disease based on an individual’s genetic, molecular, and lifestyle characteristics. Oncology precision medicine (OPM) is a cancer treatment approach targeting cancer-specific genetic and molecular alterations. Implementation of an OPM clinical program optimally involves the support and collaboration of…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Coordinating an Oncology #PrecisionMedicine Clinic w/in an Integrated Health System: Lessons Learned in Year 1 [1/28/19] @mtmdphd Godden, Wham @antonyruggeri @mullane_michael Wilson @shamsvirani Weissman, Ramczyk, Vanderwall @JimW9200 @Aurora_Cancer @JPCRR https://t.co/bxgjOfLhwk https://t.co/g0tJHnu7Xn
-
-
Mashup Score: 0Oncology precision medicine for hepatobiliary and pancreatic cancer: Insights and updates from a large community health system - 12 month(s) ago
By Geoffrey Bellini, Nicholas Sich, Jennifer Godden, et al., Published on 05/20/20
Categories: Hem/Oncs, Latest HeadlinesTweet-
Oncology #PrecisionMedicine for hepatobiliary & pancreatic cancer: Insights & updates from a large community health system [5/20/20] Bellini Sich Godden @JimW9200 @WesleyPapenfuss Chevinsky @antonyruggeri @mtmdphd @Aurora_Health Scientific Day #44 https://t.co/66KdQ3TXf3 #hpbcsm https://t.co/ONvuSh8enV
-
-
Mashup Score: 0Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response - 1 year(s) ago
Infections are a major cause of morbidity and mortality in multiple myeloma (MM), a cancer of the immune system. Vaccination clinical efficacy endpoints have not been demonstrated, and there are limited data on surrogate markers of efficacy. This pilot study evaluated sequential immunologic markers after standard pneumococcal vaccination (PV) in patients with MM and non-MM controls. Vaccination…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Multiple Myeloma IgG Level & Pneumococcal Vaccination Ab Response [Aug 10, 2017] @mtmdphd et al. @JPCRR https://t.co/x5dZNhopn5 #mmsm #ImmunoOnc #IDonc Consider: 1) homogeneous pop, 2/3) validating surrogate tests w/ outcomes, 4) larger n, 5) Epi + biomarker data https://t.co/wdB0uPMuhO
-
-
Mashup Score: 0Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies - 1 year(s) ago
Purpose: This study sought to describe the changes in immune response to a third dose of either Pfizer’s or Moderna’s COVID-19 mRNA vaccine (3V) among patients with hematologic malignancies, as well as associated characteristics Methods: This retrospective cohort study analyzed pre-3V and post-3V data on 493 patients diagnosed with hematologic malignancies across a large Midwestern health system…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Real World Third COVID19 Vaccine Dosing and Antibody Response in Patients with Hematologic Malignancies [Jul 18, 2022] @mtmdphd , Hallmeyer, @vrepublic , Liao, @mullane_michael @scmedlin , Copeland, @JimW9200 @JPCRR https://t.co/CnXLOfmBVw #COVID19nCancer #COVID19Vaccine #IDonc https://t.co/l1v0EhOopU
-
-
Mashup Score: 0
Purpose: Ovarian cancer is the most fatal of all gynecologic cancers, with a high relapse rate regardless of stage. Women treated for ovarian cancer, therefore, likely have supportive care needs that extend well beyond the time frame of first-line therapy. Unfortunately, there is minimal data describing these needs. The purpose of this qualitative study is to understand the supportive care needs…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Refining a Postpandemic Approach to Cancer Screening - 1 year(s) ago
In introducing Volume 8, Issue 4 of Journal of Patient-Centered Research and Reviews — a specially themed issue comprised of several works focused on improving cancer screening processes in clinical practice — JPCRR editor and hematologist/oncologist Michael Thompson reflects on the current state of various screening modalities and how the pandemic has already begun to shape ongoing research in…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response - 1 year(s) ago
Infections are a major cause of morbidity and mortality in multiple myeloma (MM), a cancer of the immune system. Vaccination clinical efficacy endpoints have not been demonstrated, and there are limited data on surrogate markers of efficacy. This pilot study evaluated sequential immunologic markers after standard pneumococcal vaccination (PV) in patients with MM and non-MM controls. Vaccination…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Purpose: Ovarian cancer is the most fatal of all gynecologic cancers, with a high relapse rate regardless of stage. Women treated for ovarian cancer, therefore, likely have supportive care needs that extend well beyond the time frame of first-line therapy. Unfortunately, there is minimal data describing these needs. The purpose of this qualitative study is to understand the supportive care needs…
Categories: Hem/Oncs, Latest HeadlinesTweet
A History of #BCSM and Insights for Patient-Centered Online Interaction and Engagement [Oct 23, 2020] @subatomicdoc @stales @DrAttai @JPCRR https://t.co/Mqv600RmBe #PatientDriven #openaccess #ASCO23 Figure 2 - #BCSM participants by stakeholder group https://t.co/OiVQ2XAmXZ